Robert Ossig

Oct 21, 2024 | cellandgene.com | Elben Guimaraes |Robert Ossig |Junwei Sun |Lucia Fernandez |Lucia Fernández

On-Demand Webinar - The Road to Approval: Viral Clearance Strategies for Non-Enveloped Viral VectorsDid you know that the ICH Q5A(R2) guideline is now including the expectation for viral clearance studies for non-enveloped viral vectors? Watch this webinar to get the keys to design a successful study for your AAV products. Each approach has its advantages and drawbacks, making the decision-making process crucial for your organization.

Sep 19, 2024 | bioprocessonline.com | Mike Ulman |Crystal Hostler |Mesa Laboratories |Robert Ossig

PAT: Build Quality into Biopharmaceutical Processes with Real-Time Monitoring and ControlAutomated aseptic sampling is a process analytical technology (PAT) tool that offers significant benefits for bioprocesses, including reduced contamination risk, higher measurement frequency, and improved efficiency compared to standard manual sampling. As a result, it enables improved process understanding and tighter process control. Learn more here.

Sep 10, 2024 | cellandgene.com | Robert Ossig

Article | September 10, 2024 By Robert Ossig The Handover stage of transitioning from technology transfer (TT) to commercial production is a vital phase for biopharmaceutical companies. This stage involves transferring operations from the TT Team to the Receiving Unit (RU), requiring careful coordination across multiple functions.

Aug 12, 2024 | pharmaceuticalonline.com | Robert Ossig

Article | August 12, 2024 By Robert Ossig, Process & Manufacturing Technology Explore the transformative potential of cutting-edge cell and gene therapies, focusing on CAR-T cell therapy, CRISPR-Cas9 gene editing, and other advanced approaches. CAR-T therapy involves engineering patient T cells to target and destroy cancer cells, exemplified by Kymriah for leukemia and lymphoma.

Aug 12, 2024 | cellandgene.com | Robert Ossig

Article | August 12, 2024 By Robert Ossig, Process & Manufacturing Technology Explore the transformative potential of cutting-edge cell and gene therapies, focusing on CAR-T cell therapy, CRISPR-Cas9 gene editing, and other advanced approaches. CAR-T therapy involves engineering patient T cells to target and destroy cancer cells, exemplified by Kymriah for leukemia and lymphoma.